Literature DB >> 30907202

Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short review.

Sharmila Fagoonee1, Rinaldo Pellicano2.   

Abstract

Helicobacter pylori is a human-specific pathogen with a strict tropism for the gastric mucosa. This bacterium infects around half of the world population and is the main responsible for gastritis, peptic ulcer and, in some cases, for the pathogenesis of gastric cancer. Nevertheless, disease development in infected subjects depends not only on the bacterium, but also on the host genetic predisposition and on environmental factors. The fascinating question of how the bacterium can survive in the gastric environment has stimulated research in this field. It is now clear that H. pylori is able to colonize and adhere to the gastric epithelium through several mechanisms, including the breakdown of urea with production of the cell-toxic ammonia. The resulting raise in pH neutralizes acidity of the stomach, thereby allowing the bacterium to safely cross the mucus layer to the epithelial surface. Current challenges regard understanding the mechanisms of antibiotic resistance and how to overcome it. Lately, an increasing H. pylori resistance rate to antibiotics has been reported and several molecular bases for this phenomenon described. In this review, we highlight the current knowledge on mechanisms supporting H. pylori resistance to gastric environment and to therapy.

Entities:  

Keywords:  antibiotic resistance; colonization; gastric acid; survival

Mesh:

Substances:

Year:  2019        PMID: 30907202     DOI: 10.1080/23744235.2019.1588472

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  17 in total

1.  Assessing the Synergistic Activity of Clarithromycin and Therapeutic Oils Encapsulated in Sodium Alginate Based Floating Microbeads.

Authors:  Ikram Ullah Khan; Mehwish Shoukat; Muhammad Asif; Syed Haroon Khalid; Sajid Asghar; Muhammad Usman Munir; Muhammad Irfan; Akhtar Rasul; Sameer H Qari; Alaa T Qumsani; Mohamed M Hassan; Maryam A Alahdal; Muhammad Usman; Zulqurnain Khan
Journal:  Microorganisms       Date:  2022-06-07

2.  Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients.

Authors:  Patricio González-Hormazábal; Alex Arenas; Carolina Serrano; Margarita Pizarro; Eduardo Fuentes-López; Jorge Arnold; Zoltan Berger; Maher Musleh; Héctor Valladares; Enrique Lanzarini; Lilian Jara; V Gonzalo Castro; M Constanza Camargo; Arnoldo Riquelme
Journal:  Arch Med Res       Date:  2021-02-12       Impact factor: 2.235

Review 3.  Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome.

Authors:  Joshua Bilello; Ikenna Okereke
Journal:  Biomedicines       Date:  2021-05-29

4.  Strategies for Helicobacter pylori eradication in the year 2020.

Authors:  Rinaldo Pellicano; Davide Giuseppe Ribaldone; Gian Paolo Caviglia
Journal:  Saudi J Gastroenterol       Date:  2020 Mar-Apr       Impact factor: 2.485

Review 5.  Prevalence of Helicobacter pylori Infection and Diagnostic Methods in the Middle East and North Africa Region.

Authors:  Faten A S Alsulaimany; Zuhier A Awan; Ahmad M Almohamady; Mohammed I Koumu; Bassam E Yaghmoor; Sameh S Elhady; Mahmoud A Elfaky
Journal:  Medicina (Kaunas)       Date:  2020-04-09       Impact factor: 2.430

Review 6.  Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Majid Alipour
Journal:  J Gastrointest Cancer       Date:  2020-09-14

7.  Which should be the first-line treatment for Helicobacter pylori in Colombia? A lesson from a recent study.

Authors:  Rinaldo Pellicano
Journal:  Biomedica       Date:  2019-12-01       Impact factor: 0.935

Review 8.  Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders.

Authors:  Ramsés Dávila-Collado; Oscar Jarquín-Durán; Le Thanh Dong; J Luis Espinoza
Journal:  Pathogens       Date:  2020-02-06

9.  In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains.

Authors:  Paweł Krzyżek; Roman Franiczek; Barbara Krzyżanowska; Łukasz Łaczmański; Paweł Migdał; Grażyna Gościniak
Journal:  Pathogens       Date:  2019-11-10

10.  Identifying the best regimen for primary eradication of Helicobacter pylori: analysis of 240 cases.

Authors:  Yao Chen; Qingyi Liu; Fulian Hu; Jizheng Ma
Journal:  Microbiologyopen       Date:  2020-10-07       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.